CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 279 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $145,000 | -34.4% | 1,445 | -56.7% | 0.00% | 0.0% |
| Q3 2014 | $221,000 | -21.4% | 3,334 | -17.2% | 0.00% | 0.0% |
| Q2 2014 | $281,000 | -44.6% | 4,026 | -41.9% | 0.00% | -50.0% |
| Q1 2014 | $507,000 | -1.0% | 6,928 | -6.7% | 0.00% | 0.0% |
| Q4 2013 | $512,000 | -8.1% | 7,427 | -15.3% | 0.00% | 0.0% |
| Q3 2013 | $557,000 | +18.8% | 8,766 | -9.9% | 0.00% | 0.0% |
| Q2 2013 | $469,000 | – | 9,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
| HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
| SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
| Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
| PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
| Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
| Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |